Elevance Health, Inc. (0HG8.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:41PM BST. Market open.
| Previous close | 444.50 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.175B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 0.18 |
| EPS (TTM) | 25.40 |
| Earnings date | 18 Apr 2023 - 24 Apr 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why You Should Retain Elevance (ELV) in Your Portfolio
Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
- Business Wire
Elevance Health to Host Investor Conference
INDIANAPOLIS, March 09, 2023--Elevance Health (NYSE: ELV) will host an Investor Conference with analysts and investors on March 23, 2023 in New York City. The event will feature presentations and Q&A sessions with the company’s senior leadership team.
- Zacks
The Zacks Analyst Blog Highlights UnitedHealth, Elevance Health, Humana and Centene
UnitedHealth, Elevance Health, Humana and Centene are included in this Analyst Blog.
© 2023 Yahoo. All rights reserved.
